DK1713805T3 - Kinaseinhibitorer - Google Patents

Kinaseinhibitorer

Info

Publication number: DK1713805T3
Authority: DK; Denmark
Prior art keywords: kinase inhibitors; kinase; inhibitors
Prior art date: 2004-01-30

Application number

DK05704878T

Other languages

English (en)

Inventor

Rosanne Bonjouklian

Chafiq Hamdouchi

Chuan Shih

Dios Alfonso De

Prado Miriam Filadelfa Del

Aguado Carlos Jaramillo

Pramila Kotiyan

Mary Margaret Mader

Sheila Pleite Selgas

Concepcion Sanchez-Martinez

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-01-30

Filing date

2005-01-25

Publication date

2009-08-17

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34837430&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1713805(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-01-25 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2009-08-17 Application granted granted Critical

2009-08-17 Publication of DK1713805T3 publication Critical patent/DK1713805T3/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

DK05704878T 2004-01-30 2005-01-25 Kinaseinhibitorer DK1713805T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US54083004P	2004-01-30	2004-01-30
PCT/US2005/000025 WO2005075478A1 (en)	2004-01-30	2005-01-25	Kinase inhibitors

Publications (1)

Publication Number	Publication Date
DK1713805T3 true DK1713805T3 (da)	2009-08-17

Family

ID=34837430

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK05704878T DK1713805T3 (da)	2004-01-30	2005-01-25	Kinaseinhibitorer

Country Status (26)

Country	Link
US (2)	US7582652B2 (da)
EP (1)	EP1713805B1 (da)
CN (1)	CN100516064C (da)
AR (1)	AR047466A1 (da)
AT (1)	ATE433449T1 (da)
AU (1)	AU2005210459B2 (da)
CA (1)	CA2559128C (da)
CY (1)	CY1109234T1 (da)
DE (1)	DE602005014848D1 (da)
DK (1)	DK1713805T3 (da)
DO (1)	DOP2005000010A (da)
ES (1)	ES2326819T3 (da)
HK (1)	HK1100141A1 (da)
IL (1)	IL178103A (da)
MY (1)	MY143516A (da)
NZ (1)	NZ549780A (da)
PE (1)	PE20050689A1 (da)
PL (1)	PL1713805T3 (da)
PT (1)	PT1713805E (da)
RU (1)	RU2348635C2 (da)
SI (1)	SI1713805T1 (da)
SV (1)	SV2006002001A (da)
TW (1)	TWI332003B (da)
UA (1)	UA85505C2 (da)
WO (1)	WO2005075478A1 (da)
ZA (1)	ZA200607648B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI332003B (en) *	2004-01-30	2010-10-21	Lilly Co Eli	Kinase inhibitors
US7776869B2 (en) *	2004-10-18	2010-08-17	Amgen Inc.	Heteroaryl-substituted alkyne compounds and method of use
EP1992344A1 (en)	2007-05-18	2008-11-19	Institut Curie	P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
NZ604306A (en) *	2010-05-17	2015-02-27	Incozen Therapeutics Pvt Ltd	Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinases
TWI410425B (zh) *	2010-12-03	2013-10-01	Lilly Co Eli	唑并［５，４－ｂ］吡啶－５－基化合物
PT2780011T (pt) *	2011-11-11	2018-05-14	Lilly Co Eli	Terapia de combinação para cancro do ovário
CN104640918A (zh) *	2012-07-23	2015-05-20	阿克伦大学	含有有机改性蒙脱石的基于聚异丁烯的聚氨酯
TWI731317B (zh)	2013-12-10	2021-06-21	美商健臻公司	原肌球蛋白相關之激酶（ｔｒｋ）抑制劑
TWI780438B (zh)	2014-12-18	2022-10-11	美商健臻公司	原肌球蛋白相關激酶（ｔｒｋ）抑制劑之醫藥調配物
MA41179A (fr)	2014-12-19	2017-10-24	Cancer Research Tech Ltd	Composés inhibiteurs de parg
MX371167B (es) *	2015-03-02	2020-01-21	Rigel Pharmaceuticals Inc	Inhibidores de inhibidores del factor beta de crecimiento de transformacion (tgf-beta).
PT3691620T (pt)	2017-10-05	2022-10-06	Fulcrum Therapeutics Inc	Os inibidores da quinase p38 reduzem a expressão de dux4 e genes a jusante para o tratamento de fshd
US10342786B2 (en)	2017-10-05	2019-07-09	Fulcrum Therapeutics, Inc.	P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
US10899869B2 (en)	2019-01-24	2021-01-26	The University Of Akron	Glycerol containing polyurethanes and polyurethane nanocomposites
TW202112368A (zh)	2019-06-13	2021-04-01	荷蘭商法西歐知識產權股份有限公司	用於治療有關dux4表現之疾病的抑制劑組合

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL104369A0 (en)	1992-01-13	1993-05-13	Smithkline Beecham Corp	Novel compounds and compositions
DE19503806A1 (de) *	1994-02-11	1995-08-17	Bernhardt Apparatebau Gmbh Co	Vorrichtung zum Aufblasen eines Behälters oder eines Schwimmkörpers, insbesondere einer Schwimmweste
US6426360B1 (en)	1994-07-28	2002-07-30	G D Searle & Co.	4,5-substituted imidazolyl compounds for the treatment of inflammation
US5620999A (en)	1994-07-28	1997-04-15	Weier; Richard M.	Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation
US5717100A (en)	1995-10-06	1998-02-10	Merck & Co., Inc.	Substituted imidazoles having anti-cancer and cytokine inhibitory activity
WO1998007425A1 (en)	1996-08-21	1998-02-26	Smithkline Beecham Corporation	Imidazole compounds, compositions and use
US6087496A (en)	1998-05-22	2000-07-11	G. D. Searle & Co.	Substituted pyrazoles suitable as p38 kinase inhibitors
US6180632B1 (en)	1997-05-28	2001-01-30	Aventis Pharmaceuticals Products Inc.	Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
WO1999000130A1 (en)	1997-06-30	1999-01-07	Temple University - Of The Commonwealth System Of Higher Education	Method for treating vulvar vestibulitis
AR016294A1 (es) *	1997-07-02	2001-07-04	Smithkline Beecham Corp	Compuesto de imidazol sustituido, composicion farmaceutica que la contiene, su uso en la fabricacion de un medicamento y procedimiento para supreparacion
AU1924699A (en)	1997-12-19	1999-07-12	Smithkline Beecham Corporation	Compounds of heteroaryl substituted imidazole, their pharmaceutical compositionsand uses
US6207687B1 (en)	1998-07-31	2001-03-27	Merck & Co., Inc.	Substituted imidazoles having cytokine inhibitory activity
US6291457B1 (en)	1999-07-01	2001-09-18	Merck & Co., Inc.	Compounds having cytokine inhibitory activity
ATE311385T1 (de) *	1999-10-27	2005-12-15	Novartis Pharma Gmbh	Thiazol und imidazo(4,5-b)pyridin verbindungen und ihre verwendung als pharmazeutika
GB0007405D0 (en) *	2000-03-27	2000-05-17	Smithkline Beecham Corp	Compounds
NZ526528A (en)	2001-03-09	2005-02-25	Pfizer Prod Inc	Triazolopyridines as anti-inflammatory agents
CN100540538C (zh)	2001-04-16	2009-09-16	田边三菱制药株式会社	高传导率钙-活化k通道开启剂
WO2003062215A1 (en)	2002-01-25	2003-07-31	Kylix Pharmaceuticals B.V.	4(hetero-) aryl substituted (thia-/oxa-/pyra) zoles for inhibition of tie-2
DE60304718T2 (de)	2002-08-06	2007-04-26	Astrazeneca Ab	Kondensierte pyridine und pyrimidine mit tie2 (tek) aktivität
TWI332003B (en) *	2004-01-30	2010-10-21	Lilly Co Eli	Kinase inhibitors

2005
- 2005-01-11 TW TW094100682A patent/TWI332003B/zh not_active IP Right Cessation
- 2005-01-25 AT AT05704878T patent/ATE433449T1/de active
- 2005-01-25 AU AU2005210459A patent/AU2005210459B2/en not_active Ceased
- 2005-01-25 RU RU2006138606/04A patent/RU2348635C2/ru not_active IP Right Cessation
- 2005-01-25 SI SI200530740T patent/SI1713805T1/sl unknown
- 2005-01-25 US US10/597,283 patent/US7582652B2/en not_active Expired - Fee Related
- 2005-01-25 EP EP05704878A patent/EP1713805B1/en active Active
- 2005-01-25 CN CNB2005800101425A patent/CN100516064C/zh not_active Expired - Fee Related
- 2005-01-25 UA UAA200610433A patent/UA85505C2/ru unknown
- 2005-01-25 ES ES05704878T patent/ES2326819T3/es active Active
- 2005-01-25 WO PCT/US2005/000025 patent/WO2005075478A1/en active Application Filing
- 2005-01-25 NZ NZ549780A patent/NZ549780A/en not_active IP Right Cessation
- 2005-01-25 DK DK05704878T patent/DK1713805T3/da active
- 2005-01-25 CA CA2559128A patent/CA2559128C/en not_active Expired - Fee Related
- 2005-01-25 PL PL05704878T patent/PL1713805T3/pl unknown
- 2005-01-25 PT PT05704878T patent/PT1713805E/pt unknown
- 2005-01-25 DE DE602005014848T patent/DE602005014848D1/de active Active
- 2005-01-26 AR ARP050100271A patent/AR047466A1/es not_active Application Discontinuation
- 2005-01-27 PE PE2005000103A patent/PE20050689A1/es not_active Application Discontinuation
- 2005-01-27 DO DO2005000010A patent/DOP2005000010A/es unknown
- 2005-01-27 MY MYPI20050307A patent/MY143516A/en unknown
- 2005-01-28 SV SV2005002001A patent/SV2006002001A/es not_active Application Discontinuation
2006
- 2006-09-12 ZA ZA200607648A patent/ZA200607648B/xx unknown
- 2006-09-14 IL IL178103A patent/IL178103A/en not_active IP Right Cessation
2007
- 2007-04-23 HK HK07104252.8A patent/HK1100141A1/xx not_active IP Right Cessation
2009
- 2009-07-14 CY CY20091100735T patent/CY1109234T1/el unknown
- 2009-07-27 US US12/509,886 patent/US20090318443A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US7582652B2 (en)	2009-09-01
US20090318443A1 (en)	2009-12-24
PT1713805E (pt)	2009-08-20
CA2559128A1 (en)	2005-08-18
US20090036445A1 (en)	2009-02-05
AR047466A1 (es)	2006-01-18
CA2559128C (en)	2013-04-16
SV2006002001A (es)	2006-02-15
CN100516064C (zh)	2009-07-22
TWI332003B (en)	2010-10-21
IL178103A (en)	2011-04-28
CN1938302A (zh)	2007-03-28
EP1713805A1 (en)	2006-10-25
ES2326819T3 (es)	2009-10-20
HK1100141A1 (en)	2007-09-07
RU2006138606A (ru)	2008-05-10
AU2005210459A1 (en)	2005-08-18
PL1713805T3 (pl)	2009-10-30
ATE433449T1 (de)	2009-06-15
DE602005014848D1 (de)	2009-07-23
NZ549780A (en)	2010-01-29
MY143516A (en)	2011-05-31
AU2005210459B2 (en)	2010-10-21
PE20050689A1 (es)	2005-09-27
TW200526660A (en)	2005-08-16
WO2005075478A1 (en)	2005-08-18
SI1713805T1 (sl)	2009-10-31
ZA200607648B (en)	2008-06-25
RU2348635C2 (ru)	2009-03-10
CY1109234T1 (el)	2014-07-02
EP1713805B1 (en)	2009-06-10
UA85505C2 (en)	2009-01-26
DOP2005000010A (es)	2005-11-15

Publication	Publication Date	Title
DK1704145T3 (da)	2012-09-24	Selektive kinaseinhibitorer
ATE433449T1 (de)	2009-06-15	Kinaseinhibitoren
ATE520671T1 (de)	2011-09-15	Pyrimidin-harnstoff-derivate als kinase-hemmer
ATE493403T1 (de)	2011-01-15	Kinaseinhibitoren
EP1794137A4 (en)	2009-12-02	SPECIFIC KINASE INHIBITORS
ATE505471T1 (de)	2011-04-15	Azaindol-kinaseinhibitoren
DK1979356T3 (da)	2013-11-18	Carbonylaminopyrrolopyrazoler, kraftige kinaseinhibitorer
DK2253614T3 (da)	2013-01-07	IAP-inhibitorer
DK1778718T3 (da)	2014-11-10	Iap-inhibitorer
IL177278A0 (en)	2006-12-10	Pyrazolotriazines as kinase inhibitors
IL190078A0 (en)	2008-08-07	Kinase inhibitors
DK2099447T3 (da)	2013-02-18	Imidazotriaziner og imidazopyrimidiner som kinaseinhibitorer
DK1809978T3 (da)	2014-01-20	Modul-skydebane
IL183276A0 (en)	2007-10-31	Kinase inhibitors
BRPI0716781A2 (pt)	2014-11-18	Inibidores da quinase
DE602004018837D1 (de)	2009-02-12	Ptidase-iv-inhibitoren
ITMI20041571A1 (it)	2004-10-30	Perfluoroelastomeri
ATE545642T1 (de)	2012-03-15	Mmp-inhibitoren
DK2013175T5 (da)	2020-12-21	p38 Map-kinase-inhibitorer
DK2035385T3 (da)	2010-03-22	Inhibitorer af akt (proteinkinase B)
ATE520664T1 (de)	2011-09-15	Tyrosinkinase-hemmer
ITMI20041626A1 (it)	2004-11-06	Inibitori della chinurenina-ammino-trasferasi
BRPI0719883A2 (pt)	2015-05-05	Inibidores de quinase
FR2865904B1 (fr)	2006-06-30	Calecon remonte fesses
DE602005008061D1 (de)	2008-08-21	Kinaseinhibitoren